Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
4,110 people get IYH articles and Market Currents by email alert.
Get email alerts on IYH »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
-
-
-
-
Stocks May Stumble, But Will Not FallScott Martindale • Thu, Apr 25
-
-
-
-
Tech Slips Into The RedBespoke Investment Group • Thu, Apr 18
-
-
-
-
-
-
-
-
-
To learn more about Seeking Alpha Pro, click here.
-
Monday Market Calls: U.S. Healthcare and Small CapsRuss Koesterich • Tue, Apr 19, 2011 -
-
-
-
-
-
-
-
-
Re-Evaluating Your Healthcare Exposure: A Sector ETF OverviewMorningstar • Thu, Mar 4, 2010 -
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Stocks May Stumble, But Will Not FallScott Martindale • Thu, Apr 25
-
-
-
-
Tech Slips Into The RedBespoke Investment Group • Thu, Apr 18
-
-
-
-
-
-
-
-
-
There are no Transcripts on IYH.
-
at CNBC.com (Nov 8, 2012)
-
at MarketWatch.com (Jun 28, 2012)
-
at MarketWatch.com (Jul 15, 2011)
-
at CNBC.com (Jun 14, 2011)
-
at CNBC.com (May 31, 2011)
-
at MarketWatch.com (Apr 15, 2011)
-
at MarketWatch.com (Apr 4, 2011)
IYH vs. ETF Alternatives
IYH Description
The iShares Dow Jones U.S. Healthcare Sector Index Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of U.S. healthcare stocks, as represented by the Dow Jones U.S. Health Care Index.
See more details on sponsor's website
See more details on sponsor's website
Sector: Healthcare
Country: United States
Key Info
- In Your Portfolio: A Guide to Sector ETFs, A Guide to Healthcare, Pharma and Biotech ETFs
- Asset Class Performance: Sectors
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
-
Sunday, January 27, 3:30 AM
Smaller medical-device makers such as Cardica (CRDC) are tacking surcharges on to their products or warning of price increases to cover a 2.3% sales tax that came into force on Jan. 1 as part of Obamacare. Larger manufacturers like Medtronic (MDT) and GE Healthcare (GE) haven't explicitly added extra fees but are expected to bake them into contract renewals.
13 Comments [Healthcare] - Thursday, January 24, 1:31 PM A look at the relative strength of S&P 500 sectors vs. the overall average over the past year finds 3 - Consumer Discretionary (XLY), Financials (XLF), and Health Care (XLV) outperforming. Big outperformers a few months back, Telecom (IYZ) and Utilities (XLU) now trail. Underperforming badly not long ago, Energy (XLE) and Industrials (XLI) claw their way back. 2 Comments
- Thursday, January 24, 4:48 AM The FDA won't appeal a decision to overturn the conviction of a salesmen who was found guilty of marketing narcolepsy drug Xyrem for treating drowsiness and chronic fatigue, two conditions for which the medicine wasn't approved. A court quashed the conviction because it said FDA regulations violated free speech in a decision that could have wide ramifications for the agency's ability to regulate off-label drug marketing. 3 Comments [Healthcare]
- Tuesday, January 8, 3:29 PM Vanguard's recent expense reduction means 9 of its 10 sector ETFs are now the cheapest available to U.S. investors. With an annual expense ratio of just 0.14%, VOX, VPU, VCR, VDC, VDE, VHT, VIS, VGT, and VAW stack up favorably vs. the 0.18% charged by State Street's Sector SPDRs (XLU, XLY, XLP, XLE, XLF, XLV, XLK, XLI, XLB and XTL which charges 0.35%) and the 0.47%-0.48% iShares sector ETFs (RXI, KXI, IYE, IYF, IYZ, IYH, IDU, IYW, IYM, IYJ) charge. At 0.19%, Vanguard Financials (VFH) is still slightly more expensive than the Financial SPDR (XLF). 2 Comments
- Tuesday, January 8, 6:04 AM Healthcare spending rose at a record low pace of 3.9% to $2.7T in 2011 as patients continued to cut back on medical services amid the economic slump. The growth was the same as in 2010 and 2009, and well below the 8% prior to the financial crisis. However, there are signs the rise in spending could be speeding up again, with expenditure on drugs increasing by 2.9% in 2011 vs 0.4% in 2010, and on doctors' visits by 4.3%. Comment! [Healthcare]
- Monday, January 7, 9:16 AM With the S&P at a new bull market high, Bespoke looks at sector performance since the last peak on Sept. 14. Leading the pack in the 4-month span are the financials (XLF) +5.2%, followed by Industrials (XLI) +3.6%, and Healthcare (XLV) +3.5%. Bringing up the rear are tech (XLK) -6.9% and Energy (XLE) -3.4%. Comment!
- Wednesday, January 2, 9:44 AM The Street's Adam Feuerstein makes 13 biotech stock predictions for 2013, with his number one being that the U.S. launch of Arena Pharmaceuticals' (ARNA) and Eisai's weight-loss pill Belviq "will be a major disappointment." Feuerstein also reckons that Belviq will fail to receive European approval. 17 Comments [Healthcare]
- Tuesday, January 1, 6:49 AM The number of drugs that the FDA authorized in 2012 rose to 39 from 30 last year and 21 in 2010, with the figure the highest since 53 in 1996. It also includes 10 medicines with fast-track status. The increase in approvals should help offset the patent cliff, which cost major U.S. and European drug companies $31B in revenues last year. (graph of approvals) Comment! [Healthcare]
- Sunday, December 9, 2012, 2:27 AM The Supreme Court will review a "pay for delay" case in which Solvay, now owned by Abbott Labs (ABT), paid three generic drug companies to up to $40M a year, including Watson (WPI), to postpone making copycat versions of Solvay's Androgel testosterone treatment. The case has industry wide ramifications, with the FTC saying the practice costs customers $3.5B a year. (previous) 1 Comment [Healthcare, Top Stories]
- Tuesday, December 4, 2012, 8:13 AM An appeals court ruling yesterday that dismissed the conviction of a sales rep who sold a drug for non-FDA approved uses could have major ramifications for pharmaceutical companies, which have paid billions in fines for doing just that. Two out of three judges agreed with Alfred Caronia that his rights to free speech were violated. The government is expected to appeal the case, which could find its way to the Supreme Court. 9 Comments
- Monday, November 19, 2012, 10:01 AM President Obama's re-election did not, as some believe, bring an end to the battle over Obamacare, write James Capretta and Yuval Levin in the WSJ. That's because the Administration is reliant on states for two key elements of the the reform: health-insurance exchanges and expanding Medicaid. Some GOP governors have already said "they won't do the federal government's bidding." Capretta and Levin explain why they agree. Comment! [Healthcare]
- Friday, November 16, 2012, 12:28 PM The pullback over the last 2 months is especially notable as no sector within the S&P 500 has been spared, notes Bespoke. It's extremely rare for this to happen as bear moves usually see money flow into defensive sectors like Utilities or Healthcare. With looming tax hikes on dividends and capital gains, investors are dumping it all. 13 Comments
- Wednesday, November 14, 2012, 5:21 PM A look at sector performance in the 2 months since the Fed's QE∞ announcement finds tech (XLK), -11.6% the laggard by a wide margin. The materials sector (XLB) has about matched SPY's 7.3% decline. The top performer is healthcare (XLV), -2.7%. Industrials (XLI), staples (XLP), discretionary (XLY), financials (XLF), and utilities (XLU) have marginally bested the S&P. 4 Comments
- Wednesday, November 14, 2012, 9:59 AM Obamacare is set to "take a toll" on medical-equipment companies due to a "stealth tax" on medical devices, says Tom Lydon of ETF Trends. A number of companies in the sector are planning pre-emptive layoffs in anticipation of the tax, including Medtronic (MDT) and St. Jude (STJ). Other companies in the field include [[J&J]], ISRG and BSX. ETFs worth watching include IYH, XLV, IHI and XHE. 6 Comments [Healthcare]
- Saturday, October 6, 2012, 9:00 AM The financial (XLF) and healthcare (XLV) sectors were the big winners this week, both adding to their gains relative to the S&P YTD. Another YTD outperformer, tech (XLK) combined with energy (XLE) to be the weakest sectors this week as both Apple (post-iPhone 5) and oil (post-QE∞) can't shake their hangovers. The defensive utility area (XLU) - which had a big (and worrying to some) run from mid-Spring to mid-Summer - continues to lose ground to the broader market. 3 Comments
- Tuesday, October 2, 2012, 9:58 AM Around 12M people will buy $55B worth of health coverage in 2014 via the insurance exchanges being created as part of Obamacare, PWC predicts, adding that the figures could rise to 29M people and $205B respectively by 2021. Most of the money will be new, although some will come from other parts of the market, such as from people whose employers had paid for coverage until now. 1 Comment [Healthcare]
-
Thomas Pan
Defensive health-care stocks have climbed 7.6% since October and are the top sector this quarter. IXJ IYH XLV VHT - View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
LATEST REPLIES